These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17712633)

  • 1. Biological treatment for liver tumor and new potential biomarkers.
    Chiriva-Internati M; Grizzi F; Wachtel MS; Jenkins M; Ferrari R; Cobos E; Frezza EE
    Dig Dis Sci; 2008 Mar; 53(3):836-43. PubMed ID: 17712633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunobiology and gene-based immunotherapy of hepatocellular carcinoma.
    Geissler M; Mohr L; Ali MY; Grimm CF; Ritter M; Blum HE
    Z Gastroenterol; 2003 Nov; 41(11):1101-10. PubMed ID: 14648380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential therapeutic value of dendritic cells loaded with NY‑ESO‑1 protein for the immunotherapy of advanced hepatocellular carcinoma.
    Chen Y; Huang A; Gao M; Yan Y; Zhang W
    Int J Mol Med; 2013 Dec; 32(6):1366-72. PubMed ID: 24085111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biology and clinical implications of CD133(+) liver cancer stem cells.
    Ma S
    Exp Cell Res; 2013 Jan; 319(2):126-32. PubMed ID: 22999864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of cancer-testis antigens in immunotherapy of hepatocellular carcinoma.
    Seifi-Alan M; Shamsi R; Ghafouri-Fard S
    Immunotherapy; 2018 Apr; 10(5):411-421. PubMed ID: 29473472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy for hepatocellular carcinoma.
    Li S; Yang F; Ren X
    Drug Discov Ther; 2015 Oct; 9(5):363-71. PubMed ID: 26632545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.
    Marotta F; Vangieri B; Cecere A; Gattoni A
    Clin Ter; 2004 May; 155(5):187-99. PubMed ID: 15344567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of dendritic cells by local ablation of hepatocellular carcinoma.
    Ali MY; Grimm CF; Ritter M; Mohr L; Allgaier HP; Weth R; Bocher WO; Endrulat K; Blum HE; Geissler M
    J Hepatol; 2005 Nov; 43(5):817-22. PubMed ID: 16087270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HEPATOCELLULAR CARCINOMA: CURRENT AND PROSPECTIVE IMMUNOTHERAPEUTIC STRATEGIES.
    Kikodze N; Mazmishvili K; Iobadze M; Rekhviashvili Kh; Nanava N; Pantsulaia I; Mizandari M; Janikashvili N; Chikovani T
    Georgian Med News; 2015 Sep; (246):78-84. PubMed ID: 26355320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinoma.
    Lee JH; Lee JH; Lim YS; Yeon JE; Song TJ; Yu SJ; Gwak GY; Kim KM; Kim YJ; Lee JW; Yoon JH
    Gastroenterology; 2015 Jun; 148(7):1383-91.e6. PubMed ID: 25747273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatocellular carcinoma - from immunobiology to immunotherapy].
    Flecken T; Schmidt N; Spangenberg HC; Thimme R
    Z Gastroenterol; 2012 Jan; 50(1):47-56. PubMed ID: 22222798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer vaccines for hepatocellular carcinoma: future directions.
    Buonaguro FM; Buonaguro L
    Immunotherapy; 2016; 8(4):391-3. PubMed ID: 26973120
    [No Abstract]   [Full Text] [Related]  

  • 13. Combined cancer testis antigens enhanced prediction accuracy for prognosis of patients with hepatocellular carcinoma.
    Wang M; Li J; Wang L; Chen X; Zhang Z; Yue D; Ping Y; Shi X; Huang L; Zhang T; Yang L; Zhao Y; Ma X; Li D; Fan Z; Zhao L; Tang Z; Zhai W; Zhang B; Zhang Y
    Int J Clin Exp Pathol; 2015; 8(4):3513-28. PubMed ID: 26097535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of cancer-testis antigens as biomarkers for the diagnosis and treatment of hepatocellular carcinoma.
    Grizzi F; Franceschini B; Hamrick C; Frezza EE; Cobos E; Chiriva-Internati M
    J Transl Med; 2007 Jan; 5():3. PubMed ID: 17244360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiofrequency thermal ablation of hepatocellular carcinoma liver nodules can activate and enhance tumor-specific T-cell responses.
    Zerbini A; Pilli M; Penna A; Pelosi G; Schianchi C; Molinari A; Schivazappa S; Zibera C; Fagnoni FF; Ferrari C; Missale G
    Cancer Res; 2006 Jan; 66(2):1139-46. PubMed ID: 16424051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for successful vaccination against hepatocellular carcinoma.
    Rinaldi M; Iurescia S; Fioretti D; Ponzetto A; Carloni G
    Int J Immunopathol Pharmacol; 2009; 22(2):269-77. PubMed ID: 19505380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential of immunotherapy for hepatocellular carcinoma.
    Breous E; Thimme R
    J Hepatol; 2011 Apr; 54(4):830-4. PubMed ID: 21145836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cell as therapeutic vaccines against tumors and its role in therapy for hepatocellular carcinoma.
    Sun K; Wang L; Zhang Y
    Cell Mol Immunol; 2006 Jun; 3(3):197-203. PubMed ID: 16893500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous and therapeutic immune responses in hepatocellular carcinoma: implications for current and future immunotherapies.
    Wirth TC
    Expert Rev Gastroenterol Hepatol; 2014 Jan; 8(1):101-10. PubMed ID: 24410473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of various tumor-associated antigen-specific t-cell responses in patients with hepatocellular carcinoma.
    Mizukoshi E; Nakamoto Y; Arai K; Yamashita T; Sakai A; Sakai Y; Kagaya T; Yamashita T; Honda M; Kaneko S
    Hepatology; 2011 Apr; 53(4):1206-16. PubMed ID: 21480325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.